Cargando…
Impact of neuroimaging in the pretreatment evaluation of early stage non-small cell lung cancer
BACKGROUND: There are limited data and conflicting guideline recommendations regarding the role of neuroimaging in the pretreatment evaluation of non-small cell lung cancer (NSCLC). METHODS: We performed a retrospective, pragmatic cohort study of patients with NSCLC diagnosed between January 1 and D...
Autores principales: | Wasp, Garrett T., Del Prete, Christopher, Farrell, Jonathan A.D., Dragnev, Konstantin H., Russo, Gregory, Atkins, Graham T., Phillips, Joseph D., Brooks, Gabriel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330068/ https://www.ncbi.nlm.nih.gov/pubmed/32637704 http://dx.doi.org/10.1016/j.heliyon.2020.e04319 |
Ejemplares similares
-
Hospitalization and Survival of Medicare Patients Treated With Carboplatin Plus Paclitaxel or Pemetrexed for Metastatic, Nonsquamous, Non–Small Cell Lung Cancer
por: Brooks, Gabriel A., et al.
Publicado: (2018) -
End‐of‐life quality metrics among medicare decedents at minority‐serving cancer centers: A retrospective study
por: Wasp, Garrett T., et al.
Publicado: (2020) -
Major hurdles to the use of tyrosine kinase inhibitors in clinical prevention/interception studies: Do preclinical studies with EGFR inhibitors suggest approaches to overcome some of the limitations
por: Dragnev, Konstantin H., et al.
Publicado: (2023) -
Clinical outcomes in non-small-cell lung cancer patients receiving concurrent metformin and immune checkpoint inhibitors
por: Afzal, Muhammad Z, et al.
Publicado: (2019) -
Small-cell lung cancer growth inhibition: synergism between NMDA receptor blockade and chemotherapy
por: North, William G, et al.
Publicado: (2019)